Literature DB >> 19353265

A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer.

Ava Kwong, L P Wong, H N Wong, F B F Law, E K O Ng, Y H Tang, W K Chan, L S Ho, K H Kwan, M Poon, T T Wong, F C S Leung, S W W Chan, M W L Ying, E S K Ma, J M Ford.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19353265     DOI： 10.1007/s10549-009-0385-2

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  19 in total

1.  Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations.

Authors:  Hongyi Wei; Minghao Wang; Jianghua Ou; Weihua Jiang; Fuguo Tian; Yuan Sheng; Hengyu Li; Hong Xu; Ruishan Zhang; Aihua Guan; Changqing Wang; Hongchuan Jiang; Yu Ren; Jianjun He; Jian Liu; Weiwei Huang; Ning Liao; Xiangjun Cai; Jia Ming; Rui Ling; Yan Xu; Chunyan Hu; Jianguo Zhang; Baoliang Guo; Lizhi Ouyang; Ping Shuai; Zhenzhen Liu; Ling Zhong; Ruilin Jing; Zhen Zeng; Meng Zhang; Ting Zhang; Zhaoling Xuan; Xuanni Tan; Junbin Liang; Qinwen Pan; Li Chen; Fan Zhang; Linjun Fan; Yi Zhang; Xinhua Yang; Jingbo Li; Chongjian Chen; Jun Jiang
Journal:  Oncol Lett       Date:  2018-04-18       Impact factor: 2.967

2.  Choice of management of southern Chinese BRCA mutation carriers.

Authors:  Ava Kwong; Connie H N Wong; Catherine Shea; Dacita T K Suen; Catherine L Y Choi
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

3.  Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.

Authors:  Ava Kwong; Enders Kai On Ng; Chris Lei Po Wong; Fian Bic Fai Law; Tommy Au; Hong Nei Wong; Allison W Kurian; Dee W West; James M Ford; Edmond Siu Kwan Ma
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

4.  A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer.

Authors:  Ava Kwong; Enders K O Ng; Edmund Y H Tang; Chris L P Wong; Fian B F Law; Candy P H Leung; Aaron Chan; M T Cheung; M Y To; Edmond S K Ma; Dee W West; James M Ford
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

5.  Accuracy of BRCA1/2 mutation prediction models for different ethnicities and genders: experience in a southern Chinese cohort.

Authors:  Ava Kwong; Connie H N Wong; Dacita T K Suen; Michael Co; Allison W Kurian; Dee W West; James M Ford
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

6.  Will Chinese ovarian cancer patients benefit from knowing the BRCA2 mutation status?

Authors:  Guo-Yan Liu; Wei Zhang
Journal:  Chin J Cancer       Date:  2011-12-16

7.  Elevation of methylated DNA in KILLIN/PTEN in the plasma of patients with thyroid and/or breast cancer.

Authors:  Enders K Ng; Vivian Y Shin; Candy P Leung; Vivian W Chan; Fian B Law; Man T Siu; Brian H Lang; Edmond S Ma; Ava Kwong
Journal:  Onco Targets Ther       Date:  2014-11-11       Impact factor: 4.147

8.  Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain).

Authors:  Pilar Blay; Iñigo Santamaría; Ana S Pitiot; María Luque; Marta G Alvarado; Ana Lastra; Yolanda Fernández; Angeles Paredes; José M P Freije; Milagros Balbín
Journal:  BMC Cancer       Date:  2013-05-17       Impact factor: 4.430

9.  Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients.

Authors:  Ava Kwong; Enders K O Ng; Fian B F Law; H N Wong; Anna Wa; Chris L P Wong; Allison W Kurian; Dee W West; James M Ford; Edmond S K Ma
Journal:  Breast Cancer Res Treat       Date:  2012-10-26       Impact factor: 4.872

Review 10.  Hereditary breast cancer in the Han Chinese population.

Authors:  Wenming Cao; Xiaojia Wang; Ji-Cheng Li
Journal:  J Epidemiol       Date:  2013-01-12       Impact factor: 3.211
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.